[Remote] MRD Clinical Account Executive, Sunbelt at Tempus

Georgia

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Biotechnology, Medical Devices, PharmaceuticalsIndustries

Skills

Key technologies and capabilities for this role

Precision MedicineHealthcare IndustryAI in Clinical CareReal-world EvidenceActionable InsightsMRD TestingBusiness DevelopmentStakeholder CollaborationClient AcquisitionClient RetentionLaboratory Services Agreements (LSAs)Partnership DevelopmentMarket AnalysisCompetitive LandscapeTerritory ManagementSales

Questions & Answers

Common questions about this position

What qualifications are required for the MRD Clinical Account Executive role?

Candidates need a B.S. in life science, biology, business, or marketing, with an MBA preferred, plus 3+ years of direct account management experience in a molecular diagnostic setting, focusing on MRD testing.

What key skills are needed for this position?

Required skills include proven ability in consultative selling of molecular diagnostic solutions, in-depth knowledge of oncology diagnostics reimbursement, strong communication and project management, proficiency in Microsoft Office and Salesforce, and advanced presentation skills.

Is this a remote position or does it require travel?

This information is not specified in the job description.

What is the salary or compensation for this role?

This information is not specified in the job description.

What does Tempus expect from candidates in terms of company representation?

Tempus expects representatives to embody the company culture with integrity, respect, and trust to both external and internal stakeholders.

Tempus

AI-driven healthcare data analysis platform

About Tempus

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.

Chicago, IllinoisHeadquarters

2015Year Founded

$894.9MTotal Funding

IPOCompany Stage

AI & Machine Learning, Biotechnology, HealthcareIndustries

1,001-5,000Employees